Involvement of natural killer T cells in halothane-induced liver injury in mice

Biochemical Pharmacology

Volumn 80, Issue 2, 2010, Pages 255-261

  Cheng, Linling ^a   You, Qiang ^a   Yin, Hao ^a   Holt, Michael P ^a   Ju, Cynthia ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Drug; Hepatotoxicity; Neutrophils

Indexed keywords

HALOTHANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; LIVER INJURY; LYMPHOCYTE DEPLETION; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANESTHETICS, INHALATION; ANIMALS; CLODRONIC ACID; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; HALOTHANE; KILLER CELLS, NATURAL; KUPFFER CELLS; LIVER; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS;

EID: 77952671411     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.03.025     Document Type: Article

References (34)

1. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137:947-954.
2. Temple R.J., Himmel M.H. Safety of newly approved drugs: implications for prescribing. JAMA 2002, 287:2273-2275.
3. You Q., Cheng L., Reilly T.P., Wegmann D., Ju C. Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 2006, 44:1421-1431.
4. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today 2000, 21:573-583.
5. Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000, 192:921-930.
6. Margalit M., Shibolet O., Klein A., Elinav E., Alper R., Thalenfeld B., et al. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer 2005, 115:443-449.
7. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000, 97:5498-5503.
8. Kusters S., Gantner F., Kunstle G., Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996, 111:462-471.
9. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994, 179:1529-1537.
10. Toyabe S., Seki S., Iiai T., Takeda K., Shirai K., Watanabe H., et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997, 159:1537-1542.
11. Biburger M., Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 2005, 175:1540-1550.
12. Dieli F., Sireci G., Russo D., Taniguchi M., Ivanyi J., Fernandez C., et al. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med 2000, 192:1645-1652.
13. Ogasawara K., Takeda K., Hashimoto W., Satoh M., Okuyama R., Yanai N., et al. Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol 1998, 160:3522-3527.
14. Liu Z.X., Govindarajan S., Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004, 127:1760-1774.
15. Masson M.J., Carpenter L.D., Graf M.L., Pohl L.R. Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. Hepatology 2008, 48:889-897.
16. Ju C., Pohl L.R. Immunohistochemical detection of protein adducts of 2,4-dinitrochlorobenzene in antigen presenting cells and lymphocytes after oral administration to mice: lack of a role of Kupffer cells in oral tolerance. Chem. Res. Toxicol. 2001, 14:1209-1217.
17. Cheng L., You Q., Yin H., Holt M., Franklin C., Ju C. Effect of polyI:C cotreatment on halothane-induced liver injury in mice. Hepatology 2009, 49:215-226.
18. Rafeiro E., Barr S.G., Harrison J.J., Racz W.J. Effects of N-acetylcysteine and dithiothreitol on glutathione and protein thiol replenishment during acetaminophen-induced toxicity in isolated mouse hepatocytes. Toxicology 1994, 93:209-224.
19. Sakai H., Okamoto T., Kikkawa Y. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid. J Pharmacol Exp Ther 1992, 263:381-386.
20. Stanic A.K., De Silva A.D., Park J.J., Sriram V., Ichikawa S., Hirabyashi Y., et al. Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. Proc Natl Acad Sci USA 2003, 100:1849-1854.
21. Tacke F., Luedde T., Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009, 36:4-12.
22. Tiegs G. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 2007, 45:63-70.
23. Schumann J., Wolf D., Pahl A., Brune K., Papadopoulos T., van Rooijen N., et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000, 157:1671-1683.
24. Diao H., Kon S., Iwabuchi K., Kimura C., Morimoto J., Ito D., et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004, 21:539-550.
25. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352.
26. Ruddy M.J., Shen F., Smith J.B., Sharma A., Gaffen S.L. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 2004, 76:135-144.
27. Coquet J.M., Chakravarti S., Kyparissoudis K., McNab F.W., Pitt L.A., McKenzie B.S., et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci USA 2008, 105:11287-11292.
28. Lee K.A., Kang M.H., Lee Y.S., Kim Y.J., Kim D.H., Ko H.J., et al. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell Immunol 2008, 251:50-55.
29. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204:995-1001.
30. Kobayashi E., Kobayashi M., Tsuneyama K., Fukami T., Nakajima M., Yokoi T. Halothane-induced liver injury is mediated by interleukin-17 in mice. Toxicol Sci 2009, 111:302-310.
31. Hao Q., Liu J., Pappu R., Su H., Rola R., Gabriel R.A., et al. Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages. Arterioscler Thromb Vasc Biol 2008, 28:2151-2157.
32. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
33. Paget C., Mallevaey T., Speak A.O., Torres D., Fontaine J., Sheehan K.C., et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007, 27:597-609.
34. Geissmann F., Cameron T.O., Sidobre S., Manlongat N., Kronenberg M., Briskin M.J., et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3:e113.